Steriline, a manufacturer of aseptic packaging lines for injectable and ophthalmic products, will participate in CPHI ...
CFOs are uniquely positioned to make identity readiness a value lever in M&A. We own the deal model, influence integration ...
Biomea Fusion's experimental drug showed sustained blood sugar control in patients with type 2 diabetes and may benefit those not responding to GLP-1 therapies like Novo Nordisk's Ozempic, it said on ...
The FAA’s BVLOS NPRM comment period closes as a government shutdown adds uncertainty. Industry voices concern.
Sourcing Journal on MSN
US House Panel Advances Bill Backing FMC’s ‘Get Tough on China’ Push
The bipartisan measure would extend FMC oversight through 2029, strengthen protections for U.S. shippers, and tighten ...
With increase in the applications of autonomous systems, in both civilian and military domains, it has become increasingly ...
The drugmaker has launched an international Phase I trial, dubbed Breakfree-2, in seven countries to test the autologous therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback